Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City Jan 29, 2008 Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction Jan 08, 2008 Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer Jan 08, 2008 Nektar Therapeutics' President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference Jan 02, 2008 Nektar Promotes John Nicholson to Serve as Chief Financial Officer Dec 11, 2007 Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference Nov 28, 2007 Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York Nov 14, 2007 Pfizer and Nektar Reach Agreement on Exubera(R) Nov 13, 2007 Nektar Therapeutics to Webcast R&D Day on November 14th Nov 13, 2007 Nektar Therapeutics Announces Third Quarter 2007 Financial Results Nov 07, 2007 Pagination First page « first Previous page ‹ previous … Page 43 Page 44 Page 45 Page 46 Current page 47 Page 48 Page 49 Page 50 Page 51 … Next page next › Last page last »